Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
ANIMAL VIRUSES

The C-Terminal Half of the Human Immunodeficiency Virus Type 1 Gag Precursor Is Sufficient for Efficient Particle Assembly

Alessandra Borsetti, Åsa Öhagen, Heinrich G. Göttlinger
Alessandra Borsetti
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Åsa Öhagen
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heinrich G. Göttlinger
Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JVI.72.11.9313-9317.1998
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1128/JVI.72.11.9313-9317.1998
PubMed 
9765481

Published By 
American Society for Microbiology Journals
History 
  • Received May 8, 1998
  • Accepted July 17, 1998
  • Published online November 1, 1998.

Copyright & Usage 
Copyright © 1998 American Society for Microbiology

Author Information

  1. Alessandra Borsetti,
  2. Åsa Öhagen and
  3. Heinrich G. Göttlinger*
  1. Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, and Department of Pathology, Harvard Medical School, Boston, Massachusetts 02215
  • ↵* Corresponding author. Mailing address: Dana-Farber Cancer Institute, 44 Binney St., Boston, MA 02115. Phone: (617) 632-3067. Fax: (617) 632-3113. E-mail:Heinrich_Gottlinger{at}DFCI.harvard.edu.

View Abstract

Article usage

Article usage: January 1999 to January 2021

Rendering graph...
AbstractFullPdf
Jan 19993114
Feb 1999203
Mar 1999077
Apr 1999056
May 1999203
Jun 1999131
Jul 1999044
Aug 1999153
Sep 1999005
Oct 1999012
Nov 1999125
Dec 1999027
Jan 2000346
Feb 2000036
Mar 2000112
Apr 2000038
May 2000064
Jun 2000175
Jul 200001010
Aug 2000147
Sep 2000137
Oct 2000033
Nov 2000257
Dec 2000136
Jan 2001268
Feb 2001055
Mar 2001257
Apr 2001267
May 200141310
Jun 2001045
Jul 2001137
Aug 2001020
Sep 2001062
Oct 2001185
Nov 2001123
Dec 2001061
Jan 200201016
Feb 2002154
Mar 2002025
Apr 2002013
May 20020153
Jun 2002148
Jul 2002099
Aug 2002176
Sep 2002196
Oct 20020317
Nov 2002398
Dec 2002163
Jan 200321510
Feb 200301010
Mar 2003053
Apr 2003164
May 2003078
Jun 2003096
Jul 2003551
Aug 20036124
Sep 20035119
Oct 2003775
Nov 200372119
Dec 20032106
Jan 20049126
Feb 200451110
Mar 20047166
Apr 200410176
May 20047133
Jun 2004586
Jul 2004111323
Aug 200425347
Sep 200420265
Oct 200411185
Nov 200411153
Dec 200412262
Jan 2005372
Feb 20054127
Mar 200510129
Apr 20057136
May 2005165
Jun 20056112
Jul 20053114
Aug 2005392
Sep 2005283
Oct 20052149
Nov 20051115
Dec 2005397
Jan 20066106
Feb 2006372
Mar 200651010
Apr 2006376
May 2006322
Jun 2006123
Jul 2006455
Aug 2006544
Sep 2006072
Oct 2006231
Nov 2006389
Dec 2006032
Jan 2007142
Feb 2007456
Mar 2007196
Apr 2007055
May 2007044
Jun 2007354
Jul 2007174
Aug 2007262
Sep 2007012
Oct 2007030
Nov 2007021
Dec 2007111
Jan 2008132
Feb 2008352
Mar 2008354
Apr 2008062
May 2008472
Jun 2008811
Jul 2008234
Aug 2008311
Sep 2008724
Oct 2008284
Nov 2008202
Dec 2008244
Jan 2009012
Feb 2009121
Mar 2009320
Apr 2009111
May 2009221
Jun 2009216
Jul 2009011
Aug 2009123
Sep 2009234
Oct 2009133
Nov 2009242
Dec 2009011
Jan 2010327
Feb 2010072
Mar 2010204
Apr 2010052
May 2010121
Jun 2010478
Jul 2010122
Aug 2010265
Sep 2010130
Oct 2010432
Nov 2010354
Dec 2010533
Jan 2011453
Feb 2011512
Mar 2011954
Apr 2011654
May 2011555
Jun 2011465
Jul 2011457
Aug 2011312
Sep 2011312
Oct 2011572
Nov 2011742
Dec 2011242
Jan 2012833
Feb 2012744
Mar 2012631
Apr 2012372
May 2012220
Jun 2012244
Jul 2012234
Aug 2012645
Sep 2012332
Oct 20121696
Nov 2012224
Dec 2012725
Jan 2013944
Feb 20131423
Mar 2013962
Apr 2013843
May 2013763
Jun 2013412
Jul 2013221
Aug 20131002
Sep 2013001
Oct 2013711
Nov 2013511
Dec 2013822
Jan 2014726
Feb 2014220
Mar 2014534
Apr 2014694
May 2014653
Jun 2014434
Jul 20141472
Aug 2014972
Sep 2014361
Oct 2014943
Nov 2014621
Dec 2014033
Jan 2015324
Feb 2015441
Mar 2015201
Apr 2015201
May 2015880
Jun 2015812
Jul 20151038
Aug 20151857
Sep 201523116
Oct 2015041
Nov 2015333
Dec 2015381
Jan 2016123
Feb 2016723
Mar 20162075
Apr 2016512
May 2016230
Jun 2016143
Jul 2016224
Aug 2016120
Sep 2016342
Oct 20161412
Nov 2016125
Dec 2016132
Jan 2017615
Feb 2017353
Mar 2017021
Apr 2017012
May 2017111
Jun 2017421
Jul 2017233
Aug 2017301
Sep 2017211
Oct 2017001
Nov 2017042
Feb 2018212
Mar 2018324
May 2018362
Jul 2018200
Aug 2018031
Sep 2018021
Oct 2018061
Nov 2018022
Dec 2018172
Jan 2019050
Feb 2019010
Mar 2019061
Apr 2019121
May 2019072
Jun 2019020
Jul 2019174
Aug 2019082
Sep 2019162
Oct 2019144
Nov 2019174
Dec 20192156
Jan 20202294
Feb 20202714
Mar 2020163
Apr 20200210
May 2020073
Jun 20200166
Jul 20202102
Aug 20200133
Sep 20201286
Oct 20202134
Nov 2020682
Dec 20202111
Jan 2021093
PreviousNext
Back to top
Download PDF
Citation Tools
The C-Terminal Half of the Human Immunodeficiency Virus Type 1 Gag Precursor Is Sufficient for Efficient Particle Assembly
Alessandra Borsetti, Åsa Öhagen, Heinrich G. Göttlinger
Journal of Virology Nov 1998, 72 (11) 9313-9317; DOI: 10.1128/JVI.72.11.9313-9317.1998

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
The C-Terminal Half of the Human Immunodeficiency Virus Type 1 Gag Precursor Is Sufficient for Efficient Particle Assembly
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The C-Terminal Half of the Human Immunodeficiency Virus Type 1 Gag Precursor Is Sufficient for Efficient Particle Assembly
Alessandra Borsetti, Åsa Öhagen, Heinrich G. Göttlinger
Journal of Virology Nov 1998, 72 (11) 9313-9317; DOI: 10.1128/JVI.72.11.9313-9317.1998
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Gene Products, gag
HIV-1
Peptide Fragments
Protein Precursors

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514